Morgan Stanley Finance LLC Files New Securities Prospectus
| Field | Detail |
|---|---|
| Company | Morgan Stanley Finance LLC |
| Form Type | 424B2 |
| Filed Date | Mar 24, 2026 |
| Risk Level | medium |
| Pages | 16 |
| Reading Time | 19 min |
| Key Dollar Amounts | $1,000, $898.90, $48.90, $9.583, $0 |
| Sentiment | neutral |
Complexity: moderate
Sentiment: neutral
Topics: debt-offering, prospectus, capital-raise, securities-issuance
Related Tickers: MS
TL;DR
**MS is issuing new securities, watch for debt impact.**
AI Summary
Morgan Stanley Finance LLC, a subsidiary of Morgan Stanley, filed a 424B2 prospectus on March 24, 2026, under File No. 333-275587-01. This filing, specifically Preliminary Pricing Supplement No. 15,116, indicates the offering of new securities. For investors, this means Morgan Stanley Finance is raising capital, which could impact the company's debt levels and future financial obligations, potentially affecting the parent company's stock valuation.
Why It Matters
This filing signals Morgan Stanley Finance LLC is issuing new securities to raise capital, which could affect the company's financial structure and future earnings.
Risk Assessment
Risk Level: medium — The issuance of new securities can increase a company's debt burden or dilute existing shareholder value, depending on the type of security.
Analyst Insight
Investors should monitor subsequent filings to understand the specific terms of the new securities, such as interest rates, maturity dates, and any conversion features, to assess the potential impact on Morgan Stanley's financial health and stock.
Key Numbers
- 2026-03-24 — Filing Date (Date the 424B2 prospectus was filed by Morgan Stanley Finance LLC.)
- 15,116 — Pricing Supplement Number (Identifies the specific preliminary pricing supplement for the new securities offering.)
Key Players & Entities
- Morgan Stanley Finance LLC (company) — Filer of the 424B2 prospectus
- Morgan Stanley (company) — Parent company of the filer
- 0001666268 (person) — CIK for Morgan Stanley Finance LLC
- 0000895421 (person) — CIK for Morgan Stanley
- 333-275587-01 (dollar_amount) — File number for Morgan Stanley Finance LLC's registration statement
- 333-275587 (dollar_amount) — File number for Morgan Stanley's registration statement
- 15,116 (dollar_amount) — Preliminary Pricing Supplement number
- 2026-03-24 (dollar_amount) — Filing and acceptance date
FAQ
What is the purpose of the 424B2 filing by Morgan Stanley Finance LLC?
The 424B2 filing, specifically Preliminary Pricing Supplement No. 15,116, is a prospectus for the offering of new securities by Morgan Stanley Finance LLC, as indicated by the document description 'PRELIMINARY PRICING SUPPLEMENT NO. 15,116 ms15116_424b2-10721.htm'.
When was this 424B2 filing submitted and accepted by the SEC?
The 424B2 filing by Morgan Stanley Finance LLC was filed on 2026-03-24 and accepted on 2026-03-24 11:17:43, according to the filing details.
Filing Stats: 4,710 words · 19 min read · ~16 pages · Grade level 16.4 · Accepted 2026-03-24 11:17:43
Key Financial Figures
- $1,000 — an Stanley Stated principal amount: $1,000 per security Issue price: $1,000 pe
- $898.90 — ue on the pricing date: Approximately $898.90 per security, or within $48.90 of that
- $48.90 — imately $898.90 per security, or within $48.90 of that estimate. See "Estimated Value
- $9.583 — r annum (corresponding to approximately $9.583 per interest period per security). The
- $0 — ( less than the coupon barrier level) $0 Hypothetical Observation Date #3 90
- $19.166 — upon barrier level) $9.583 + $9.583 = $19.166 Hypothetical Observation Date #4 25
- $450.00 — ) = $1,000 [ (30.00 / 100.00) + 15% ] = $450.00 In example #1, the final level is gre
Filing Documents
- ms15116_424b2-10721.htm (424B2) — 308KB
- image1.gif (GRAPHIC) — 119KB
- 0001839882-26-016602.txt ( ) — 474KB
Risk Factors
Risk Factors This section describes the material risks relating to the securities. For further discussion of these and other risks, you should read the section entitled "Risk Factors" in the accompanying product supplement, index supplement and prospectus. We also urge you to consult with your investment, legal, tax, accounting and other advisers in connection with your investment in the securities. Risks Relating to an Investment in the Securities The securities provide for only the minimum payment at maturity. The terms of the securities differ from those of ordinary debt securities in that they provide for only the minimum payment at maturity. If the securities have not been automatically redeemed prior to maturity and the final level is less than the buffer level, the payout at maturity will be an amount in cash that is less than the stated principal amount of each security, and you will lose an amount proportionate to the full decline in the level of the underlier over the term of the securities beyond the buffer amount. You could lose a significant portion of your initial investment in the securities. The securities do not provide for the regular payment of interest. The terms of the securities differ from those of ordinary debt securities in that they do not provide for the regular payment of interest. Instead, the securities will pay a contingent coupon on a coupon payment date but only if the closing level of the underlier is greater than or equal to the coupon barrier level on the related observation date. However, if the closing level of the underlier is less than the coupon barrier level on any observation date, we will pay no coupon with respect to the applicable interest period. Any such unpaid contingent coupon will be paid on a subsequent coupon payment date but only if the closing level of the underlier is greater than or equal to the coupon barrier level on the related observation date. You will not receive payment for any such unpaid conti